During the past decade, Medicor Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medicor Cardiology" #1 sponsor was "Bayer" with 1 trials, followed by "Biosite" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Cardionet" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medicor Cardiology" #1 collaborator was "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medicor Cardiology" are "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (1 trials), "Heart Failure" (1 trials), "High Cardiovascular Risk" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Medicor Cardiology" in a lesser frequency.

Most popular intervention types in "Medicor Cardiology" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medicor Cardiology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Medicor Cardiology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medicor Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medicor Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".